Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Drug trial tests doses to help patients swallow safely

NCT ID NCT05551182

Summary

This study tested whether a lower or higher dose of the drug nicergoline was better at improving swallowing problems (dysphagia) in adults. It involved 92 people with stroke, Parkinson's disease, or dementia who had trouble swallowing. Researchers compared how much swallowing improved and monitored side effects over 12 weeks to find the best dose.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DYSPHAGIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Phramongkutklao Hospital

    Ratchathewi, Bangkok, 10400, Thailand

Conditions

Explore the condition pages connected to this study.